Difluprednate (Visiox Pharma)
二氟泼尼酯 (Visiox Pharma)
Report date: 2026/01/21 16:31:04
Base Information
Drug NameDifluprednate (Visiox Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSun Pharma Advanced Research Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSun Pharma Advanced Research Company LtdChina Medical System Holdings LtdVisiox Pharma LLC
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A